GLP1R and type 2 diabetes mellitus: Among glucose-lowering medications, glucagon-like peptide 1 receptor agonists (GLP-1RAs) are considered the first-line therapy in people with type 2 diabetes based on their metabolic and cardiovascular efficacy.